Associated Papers
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors.
Buelow DR et al.
Blood Advances, 2022
35797240 (PubMed )
Supplement: advancesADV2022007952-suppl2.xlsx › Suppl_table_7
Frequency and Clinicopathologic Features of RUNX1 Mutations in Patients With Acute Myeloid Leukemia Not Otherwise Specified.
You E et al.
American Journal of Clinical Pathology, 2017
Select a paper to view details